Biggest News Aggregation in the World
๐Ÿ“ฐ Intelligence Analysis News

Page 21 - Intelligence Analysis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Intelligence Analysis. Real-time updates on events, politics, business and more.

DelveInsight Business Research LLP: Chemotherapy-induced Peripheral Neuropathy Market to Witness Upsurge in Growth at a CAGR of 3.1% by 2032, Predicts DelveInsight

The chemotherapy-induced peripheral neuropathy market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also the launch of upcoming therapies during
United Kingdom United States Gewinn Nur Asahi Kasei Prnewswire Delveinsight Shruti Thakur

DelveInsight Business Research, LLP: Psychosis in Parkinson's and Alzheimer's Disease Market to Observe Stunning Growth at a CAGR of 15.6% in the US During the Study Period (2019-2032), Examines DelveInsight

The psychosis in Parkinson's and Alzheimer's disease market size shall grow during the forecast period (2023-2032). This increase will be due to rising disease awareness and improving diagnosis
United Kingdom Gewinn Nur Shruti Thakur Sumitomo Pharma Inmune Bio Teva Pharmaceutical Industries Ltd

DelveInsight Business Research, LLP: Cocaine Use Disorder Market to Observe Impressive Growth at a Significant CAGR of 18.1% During the Study Period (2019-2032), Assesses DelveInsight

The cocaine use disorder market is expected to increase owing to the increasing awareness and increasing diagnosed prevalent population. Moreover, the expected launch of emerging therapies,
United Kingdom United States Prnewswire Delveinsight Embera Neurotherapeutics Camino Pharma Shruti Thakur

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

DelveInsight Business Research, LLP: PD1 and PDL1 Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Incyte Corporation, Bristol-Myers Squibb, Novartis, Bayer, Beigene, Merck, AbbVie, and Others Expected to Propel Market

The PD-1 and PD-L1 inhibitors market is anticipated to be driven in the coming years due to the rise in novel drugs and therapies and the increase in healthcare spending across the world. In
Shruti Thakur Bristol Myers Squibb Chugai Pharma Prnewswire Delveinsight Drug Administration Boehringer Ingelheim

DelveInsight Business Research, LLP: Significant Positive Shift in the Cell and Gene Therapies in Rare Disorders Market with 35.8% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight

The dynamics of the cell and gene therapies market in rare disorders are anticipated to change as companies across the globe are thoroughly working toward developing new therapeutic options
United States United Kingdom Novartis Avexis Shruti Thakur Gensight Biologics Johnson Meiragtx

DelveInsight Business Research, LLP: Acute Ischemic Stroke Market is Expected to Showcase Significant Growth at a CAGR of 10.6% During the Study Period (2019-2032), Predicts DelveInsight

The dynamics of the acute ischemic stroke (AIS) market are anticipated to change during the forecast period (2023-2032) owing to the improved knowledge of stroke pathophysiology, awareness of
United Kingdom United States Shruti Thakur Athersys Healios Asundexian Bayer Bristol Myers Squibb Janssen

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science